Biotest AG logo

BIO3 - Biotest AG News Story

€29.8 0.0  0.0%

Last Trade - 12/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.02bn
Enterprise Value £1.35bn
Revenue £419.7m
Position in Universe 387th / 1046

BRIEF-Biotest 9-mth revenue at EUR 377.8 mln

Tue 14th November, 2017 8:00am
Nov 14 (Reuters) - BIOTEST AG  BIOG.DE : 
    * DGAP-NEWS: BIOTEST AG: BIOTEST GENERATES REVENUES OF EUR 377.8 MILLION IN THE FIRST NINE 
MONTHS 
2017 
    * 9M REVENUE 377.8 MILLION EUR 
    * PAUL-EHRLICH INSTITUTE APPROVES PHASE III TRIAL IN INDICATION OF ACQUIRED FIBRINOGEN 
DEFICIENCY 
    * EBIT OF CONTINUING OPERATIONS TOTALED EUR -15.7 MILLION IN FIRST THREE QUARTERS OF 2017 
AFTER 
EUR 47.5 MILLION 
    * 9-MONTH EARNINGS AFTER TAXES OF CONTINUING OPERATIONS OF EUR -22.7 MILLION VERSUS EUR 
13.3 
MILLION YEAR AGO 
 
Source text for Eikon:  ID:nEQc49CrHa  
Further company coverage:  BIOG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.